- Report
- August 2025
- 197 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2025
- 186 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2025
- 196 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2025
- 180 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2025
- 185 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2025
- 192 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2025
- 188 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- February 2024
- 116 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- May 2025
- 130 Pages
Global
From €5337EUR$5,950USD£4,563GBP
- Report
- March 2025
- 120 Pages
Global
From €5337EUR$5,950USD£4,563GBP
- Report
- October 2023
- 145 Pages
Global
From €2826EUR$3,150USD£2,416GBP
- Report
- July 2022
- 317 Pages
Global
From €3140EUR$3,500USD£2,684GBP
- Report
- August 2025
- 192 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2025
- 195 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- August 2025
- 191 Pages
Global
From €3180EUR$3,545USD£2,719GBP
€3534EUR$3,939USD£3,021GBP
- Report
- December 2024
- 175 Pages
Global
From €4485EUR$5,000USD£3,834GBP
- Report
- January 2025
- 133 Pages
Europe
From €3588EUR$4,000USD£3,068GBP
- Report
- June 2025
- 150 Pages
Global
From €3364EUR$3,750USD£2,876GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2915EUR$3,250USD£2,492GBP
- Report
- May 2025
- 170 Pages
Global
From €4171EUR$4,650USD£3,566GBP

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases.
Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs.
The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs.
Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more